These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3029923)

  • 1. Cell-mediated immune responses in rat cytomegalovirus infection.
    Esa AH; Vogelsang GB; Sandford GR; Saral R; Hess AD; Burns WH
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2726-9. PubMed ID: 3029923
    [No Abstract]   [Full Text] [Related]  

  • 2. The importance of cytotoxic cellular immunity in the protection from cytomegalovirus infection.
    Quinnan GV; Rook AH
    Birth Defects Orig Artic Ser; 1984; 20(1):245-61. PubMed ID: 6329365
    [No Abstract]   [Full Text] [Related]  

  • 3. Rat cytomegalovirus can be transferred by bone marrow cells but does not affect the course of acute graft-versus-host disease.
    Bos GM; Majoor GD; Bruggeman CA; Grauls G; van de Gaar MJ; van Breda Vriesman PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3050-2. PubMed ID: 2539684
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhancement of obliterative airway disease in rat tracheal allografts infected with recombinant rat cytomegalovirus.
    Reichenspurner H; Soni V; Nitschke M; Berry GJ; Brazelton T; Shorthouse R; Huang X; Boname J; Girgis R; Raitz BA; Mocarski E; Sandford G; Morris RE
    J Heart Lung Transplant; 1998 May; 17(5):439-51. PubMed ID: 9628562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of cytomegalovirus infection and acute rejection after allogeneic lung transplantation in the rat: virus-induced expression of major histocompatibility complex class II antigens.
    You XM; Steinmüller C; Wagner TO; Bruggeman CA; Haverich A; Steinhoff G
    J Heart Lung Transplant; 1996 Nov; 15(11):1108-19. PubMed ID: 8956120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection.
    Lemström KB; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ
    Am J Pathol; 1994 Jun; 144(6):1334-47. PubMed ID: 8203471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role of bone marrow transplantation in augmenting donor-derived immunity to hepatitis B after rat liver transplantation.
    Li J; Dahmen U; Dirsch OR; Gu Y; Polywka S; Fiedler M; Doebel L; Roggendorf M; Broelsch CE
    Liver Transpl; 2002 Apr; 8(4):397-404. PubMed ID: 11965586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a combined antigen-cyclosporine regimen in four transplantation models.
    Didlake R; Kakazaki K; Yoshimura N; Merrell R; Kahan BD
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1281-3. PubMed ID: 3152626
    [No Abstract]   [Full Text] [Related]  

  • 9. Virus-specific cytotoxic lymphocyte responses are predictive of the outcome of cytomegalovirus infection of renal transplant recipients.
    Rook AH; Smith WJ; Burdick JF; Manischewitz JF; Frederick W; Siegel JP; Williams GM; Quinnan GV
    Transplant Proc; 1984 Dec; 16(6):1466-9. PubMed ID: 6095498
    [No Abstract]   [Full Text] [Related]  

  • 10. Synergistic effect of UV-irradiated donor-specific transfusions with peritransplant cyclosporine on cardiac allograft survival in rats.
    Oluwole S; Lau H; Reemtsma K; Hardy MA
    Transplant Proc; 1987 Feb; 19(1 Pt 1):451-3. PubMed ID: 3274803
    [No Abstract]   [Full Text] [Related]  

  • 11. Transfer of cytomegalovirus infection via renal allografts: role of immunosuppressive regimens on the transfer rate, and effect of cytomegalovirus infections on renal allograft rejection; study in a rat model.
    Bruning JH; Bruggeman CA; van Breda Vriesman PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2089-90. PubMed ID: 2540562
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo and in vitro measurement of sensitization to rat marrow allografts.
    Klein DL; Bateman JL; Sepelak SB; Tutschka PJ; Elfenbein GJ; Santos GW
    Transplant Proc; 1978 Jun; 10(2):435-40. PubMed ID: 354134
    [No Abstract]   [Full Text] [Related]  

  • 13. Thalidomide induction of bone marrow transplantation tolerance.
    Vogelsang GB; Hess AD; Gordon G; Brundrette R; Santos GW
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2658-61. PubMed ID: 3547944
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of graft-versus-host disease after bone marrow and small bowel transplantation by ultraviolet B modulation of bone marrow cells.
    Chowdhury NC; Jin MX; Hardy MA; Oluwole SF
    Transplant Proc; 1993 Feb; 25(1 Pt 1):475-6. PubMed ID: 8438384
    [No Abstract]   [Full Text] [Related]  

  • 15. Natural killer activity against viral targets in cyclosporine-treated renal allograft recipients.
    Cauda R; Citterio F; Tamburrini E; Pozzetto U; Tumbarello M; Castagneto M; Ortona L
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):186-9. PubMed ID: 2834839
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of Kilham rat virus on natural killer cell-mediated cytotoxicity in brown Norway and Wistar Furth rats.
    Darrigrand AA; Singh SB; Lang CM
    Am J Vet Res; 1984 Jan; 45(1):200-2. PubMed ID: 6200013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
    Colson YL; Zadach K; Nalesnik M; Ildstad ST
    Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft-versus-leukemia in the rat--the antileukemic efficacy of syngeneic and allogeneic graft-versus-host disease.
    Tutschka PJ; Berkowitz SD; Tuttle S; Klein J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2668-73. PubMed ID: 3547945
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection.
    Orange JS; Biron CA
    J Immunol; 1996 Jun; 156(12):4746-56. PubMed ID: 8648121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated immunity to cytomegalovirus in mice and in renal transplant recipients.
    Howard RJ; Balfour HH
    Transplant Proc; 1979 Mar; 11(1):75-8. PubMed ID: 222021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.